Results 61 to 70 of about 18,888 (217)

The Dental Status of Patients Taking Common Biologic Agents: A Single‐Center Cross‐Sectional Study

open access: yesOral Diseases, EarlyView.
ABSTRACT Objectives Despite expanding use and medical applications, little is known about the impact of biologic agents (BAs) on dental treatment. The aim of this study was to investigate the dental status of patients on common classes of BAs to understand treatment needs and use in this population.
Shivani Shah   +4 more
wiley   +1 more source

The Current State of Clinical Diagnostic Algorithms for Mucosal Oral Lesions: A Scoping Review

open access: yesOral Diseases, EarlyView.
ABSTRACT Background Diagnosing oral lesions remains challenging for many dentists. Despite the availability of diagnostic algorithms, there is a dearth of comprehensive evidence synthesis and a discussion on their clinical and pedagogical applicability.
Mohammed Al‐Shehri   +7 more
wiley   +1 more source

Bullous pemphigoid in infancy

open access: yes
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Jovine Ehrenreich   +4 more
wiley   +1 more source

Mucoadhesive Drug Delivery Systems for Oral Chronic Inflammatory Mucosal Diseases. The Future is Already Present. A Systematic Review

open access: yesOral Diseases, EarlyView.
ABSTRACT Background Oral lichen planus (OLP) and recurrent aphthous stomatitis (RAS) are considered the most painful oral inflammatory diseases, with high global prevalence and significant impacts on patients' quality of life. In the last decades, researchers have been exploring mucoadhesive drug delivery systems (MDDS) to improve drugs safety and ...
M. E. Mauceri   +7 more
wiley   +1 more source

Pemphigoid gestationis

open access: yesDermatology Online Journal, 2010
Pemphigoid gestationis is a rare autoimmune blistering disease of pregnancy. It is characterized by pruritic, urticarial plaques with the development of tense vesicles and bullae within the lesions. Pemphigoid gestationis has been associated with premature delivery, small-for-gestational-age infants.
Lu, Phoebe D   +3 more
openaire   +4 more sources

Treatment of juvenile bullous pemphigoid with lebrikizumab

open access: yes
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Marcel Wittenberg   +6 more
wiley   +1 more source

Autoantibodies and Inflammation in Schizophrenia

open access: yesPsychiatry and Clinical Neurosciences, EarlyView.
The potential role of autoantibodies in the etiology of schizophrenia is a key research focus because growing evidence suggests an association between immune dysfunction and psychotic disorders. This hypothesis is supported by findings indicating immune‐related abnormalities in patients with schizophrenia, including chronic inflammation and genetic ...
Hiroki Shiwaku
wiley   +1 more source

Neonatal Epidermolytic Ichthyosis Caused by a KRT10 Mutation (c.467G>A, p.Arg156His): A Case Report

open access: yesClinical Case Reports, Volume 13, Issue 8, August 2025.
ABSTRACT We present a neonatal case of skin blisters and erythema. While epidermolysis bullosa was initially suspected, immunofluorescence antigen mapping and genetic testing confirmed epidermolytic ichthyosis, with a heterozygous pathogenic variant in the KRT10 gene (c.467G>A, p.Arg156His).
Elke Smits   +4 more
wiley   +1 more source

Clinical Characteristics and Survival of Pemphigoid and Pemphigus Patients in a Thai Population

open access: yesSiriraj Medical Journal
Objective: Pemphigoid and pemphigus are skin diseases with high morbidity and mortality. The research aims to study the clinical presentations, comorbidities, and medications used prior to diagnosis, as well as the survival rates and prognostic factors ...
Kamontorn Insan   +7 more
doaj  

SARS-CoV-2 infections in patients with autoimmune blistering disorders: A case series and retrospective analysisCapsule Summary

open access: yesJAAD International, 2022
Background: Autoimmune blistering disorders (AIBDs) are rare, potentially life-threatening conditions often requiring immunosuppression. Throughout the SARS-CoV-2 pandemic, infection risk and mortality in patients with AIBDs are unknown.
Kimberly F. Breglio, MD, DPhil   +3 more
doaj  

Home - About - Disclaimer - Privacy